JP2023538236A5 - - Google Patents
Info
- Publication number
- JP2023538236A5 JP2023538236A5 JP2023504727A JP2023504727A JP2023538236A5 JP 2023538236 A5 JP2023538236 A5 JP 2023538236A5 JP 2023504727 A JP2023504727 A JP 2023504727A JP 2023504727 A JP2023504727 A JP 2023504727A JP 2023538236 A5 JP2023538236 A5 JP 2023538236A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- liver disease
- peptide
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2020-0102604 | 2020-08-14 | ||
| KR20200102604 | 2020-08-14 | ||
| KR10-2021-0048006 | 2021-04-13 | ||
| KR20210048006 | 2021-04-13 | ||
| PCT/KR2021/010910 WO2022035302A1 (ko) | 2020-08-14 | 2021-08-17 | 글루카곤, glp-1 및 gip 수용체 모두에 활성을 갖는 삼중 활성체를 포함하는 혈압 강하용 약학 조성물 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538236A JP2023538236A (ja) | 2023-09-07 |
| JP2023538236A5 true JP2023538236A5 (cg-RX-API-DMAC7.html) | 2024-08-27 |
Family
ID=80247176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023504727A Pending JP2023538236A (ja) | 2020-08-14 | 2021-08-17 | グルカゴン、glp-1及びgip受容体の全てに対して活性を有する三重活性体を含む血圧降下用薬学組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240024426A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4197550A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023538236A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220021895A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116322786A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021326369A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3188884A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL300017A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023001601A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022035302A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023537895A (ja) * | 2020-08-14 | 2023-09-06 | ハンミ ファーマシューティカル カンパニー リミテッド | 三重活性体持続型結合体を有効成分として含む薬学組成物 |
| WO2022065897A1 (ko) * | 2020-09-25 | 2022-03-31 | 한미약품 주식회사 | 글루카곤, glp-1 및 gip 수용체 모두에 활성을 갖는 삼중 활성체 또는 이의 결합체의 신경퇴행성 질환의 치료 용도 |
| EP4230218A4 (en) * | 2020-10-16 | 2024-11-20 | Hanmi Pharm. Co., Ltd. | Pharmaceutical composition comprising glucagon/glp-1/gip triple agonist or long-acting conjugate thereof for preventing or treating vasculitis |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| CA2249195A1 (en) | 1996-03-18 | 1997-09-25 | Board Of Regents, The University Of Texas System | Immunoglobin-like domains with increased half lives |
| AU2014345570B2 (en) * | 2013-11-06 | 2019-01-24 | Zealand Pharma A/S | Glucagon-GLP-1-GIP triple agonist compounds |
| JP6280398B2 (ja) * | 2014-03-04 | 2018-02-14 | 株式会社ナガセビューティケァ | Glp−1分泌促進剤 |
| TWI772252B (zh) * | 2014-09-16 | 2022-08-01 | 南韓商韓美藥品股份有限公司 | 長效glp-1/高血糖素受體雙促效劑治療非酒精性脂肝疾病之用途 |
| FI3322437T3 (fi) * | 2015-06-30 | 2024-02-20 | Hanmi Pharmaceutical Co Ltd | Glukagonijohdannainen ja sen pitkävaikutteisen konjugaatin käsittävä koostumus |
| US20180360973A1 (en) * | 2015-12-02 | 2018-12-20 | Hanmi Pharm. Co., Ltd. | Protein conjugate using a fatty acid derivative and method for preparation thereof |
| JP6712323B2 (ja) * | 2015-12-31 | 2020-06-17 | ハンミ ファーマシューティカル カンパニー リミテッド | グルカゴン、glp−1及びgip受容体のすべてに活性を有する三重活性体 |
| AR110300A1 (es) * | 2016-12-02 | 2019-03-13 | Sanofi Sa | Compuestos como agonistas peptídicos trigonales de los receptores de glp1 / glucagón / gip |
| JP2023537895A (ja) * | 2020-08-14 | 2023-09-06 | ハンミ ファーマシューティカル カンパニー リミテッド | 三重活性体持続型結合体を有効成分として含む薬学組成物 |
-
2021
- 2021-08-17 WO PCT/KR2021/010910 patent/WO2022035302A1/ko not_active Ceased
- 2021-08-17 MX MX2023001601A patent/MX2023001601A/es unknown
- 2021-08-17 JP JP2023504727A patent/JP2023538236A/ja active Pending
- 2021-08-17 US US18/041,151 patent/US20240024426A1/en active Pending
- 2021-08-17 IL IL300017A patent/IL300017A/en unknown
- 2021-08-17 AU AU2021326369A patent/AU2021326369A1/en active Pending
- 2021-08-17 EP EP21856308.8A patent/EP4197550A4/en active Pending
- 2021-08-17 CA CA3188884A patent/CA3188884A1/en active Pending
- 2021-08-17 CN CN202180063776.6A patent/CN116322786A/zh active Pending
- 2021-08-17 KR KR1020210108368A patent/KR20220021895A/ko active Pending